Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer
The reasons behind the poor efficacy of transition metal-based chemotherapies (e.g., cisplatin) or targeted therapies (e.g., histone deacetylase inhibitors, HDACi) on gastric cancer (GC) remain elusive and recent studies suggested that the tumor microenvironment could contribute to the resistance. H...
Main Authors: | Aina Venkatasamy, Eric Guerin, Anais Blanchet, Christophe Orvain, Véronique Devignot, Matthieu Jung, Alain C. Jung, Marie-Pierre Chenard, Benoit Romain, Christian Gaiddon, Georg Mellitzer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/9/1485 |
Similar Items
-
The Effect of Vicinal Difluorination on the Conformation and Potency of Histone Deacetylase Inhibitors
by: A. Daryl Ariawan, et al.
Published: (2021-06-01) -
HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway
by: Marie-Elodie Spaety, et al.
Published: (2019-11-01) -
Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines
by: Susanna Nencetti, et al.
Published: (2021-01-01) -
Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
by: Maria Mrakovcic, et al.
Published: (2017-08-01) -
Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats
by: Xiao-Tao He, et al.
Published: (2018-05-01)